NOREPINEPHRINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norepinephrine, and what generic alternatives are available?
Norepinephrine is a drug marketed by Amneal, Anthea Pharma, Aspiro, Baxter Hlthcare Corp, Biocon Pharma, Breckenridge, Caplin, Fresenius Kabi Usa, Gland, Hikma, Meitheal, Metrics Pharm, MSN, Mylan Labs Ltd, Rising, Sandoz, Sun Pharm, Zydus Pharms, Inforlife, Long Grove Pharms, and Sagent. and is included in twenty-four NDAs. There are twelve patents protecting this drug.
The generic ingredient in NOREPINEPHRINE is norepinephrine bitartrate. There are five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norepinephrine
A generic version of NOREPINEPHRINE was approved as norepinephrine bitartrate by MEITHEAL on March 3rd, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NOREPINEPHRINE?
- What are the global sales for NOREPINEPHRINE?
- What is Average Wholesale Price for NOREPINEPHRINE?
Summary for NOREPINEPHRINE
| US Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 24 |
| Drug Prices: | Drug price information for NOREPINEPHRINE |
| What excipients (inactive ingredients) are in NOREPINEPHRINE? | NOREPINEPHRINE excipients list |
| DailyMed Link: | NOREPINEPHRINE at DailyMed |
